Athenex Exits 503B Sterile Compounding Business
BUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel…
Recover your password.
A password will be e-mailed to you.